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Neurodynamic treatment improves leg pain, back pain, function and global
perceived effect at 4 weeks in patients with chronic nerve-related leg painWe are concerned about the reporting of the trial ‘Neurody-
namic treatment did not improve pain and disability at two weeks
in patients with chronic nerve-related leg pain’.1 [1_TD$DIFF] There is a
tendency to simplify the ﬁndings of clinical trials into binary
conclusions (either positive or negative) based on the analysis of
the primary outcomes.2 Often, a more nuanced interpretation is
required by thoroughly examining the totality of the evidence, not
just the primary outcomes.2 In our opinion, this nuance is lacking
in the study by Ferreira et al.1 If we follow their conclusions, we
risk discarding valuable interventions, as is evident from their
own1 and other studies.3
In line with their protocol paper, the authors prioritised
immediate treatment effects (ie, immediately after a 2-week
intervention) over intermediate follow-up (4 weeks after baseline,
or 2weeks after the last treatment session). This is unconventional.
Intermediate and long-term effects should have priority over
immediate effects.4 The choice of primary outcomes was, in our
view, suboptimal and unfortunate, and greatly impacted the
study’s conclusions. A different and probably more logical
selection of primary outcomes (eg, leg or back pain, function or
global perceived effect at 4 weeks) would have led to the opposite
conclusion. This favourable conclusionwould have been consistent
with the ﬁndings from a clinical trial on neurodynamics for nerve-
related neck-arm pain,3 on which the design of this study was
modelled. Although our somewhat provocative title might suggest
otherwise, we obviously do not advocate selective reporting of
planned secondary outcomes. More nuance is and was required.
The study aimed to compare, at two timepoints, the effect of
neurodynamic treatment versus wait-and-see on leg pain,
disability, back pain, function, global perceived effect, and the
proportion of participants whose leg pain centralised. The title,
conclusions and choice of primary outcomes should better reﬂect
all aims of the study. Leg pain and disability were primary
outcomes immediately after treatment, but were not considered
important enough to be primary outcomes at 4 weeks. We fail to
see the rationale behind this. In a trial where rapid change would
be unexpected, 4-week outcomes seem more important because:
only four treatment sessions were prescribed in patients with
a chronic condition, and neuropathic pain and nerve root1836-9553/ 2016 Australian Physiotherapy Association. Published by Elsevier B
creativecommons.org/licenses/by-nc-nd/4.0/).compromise, which are likely indicators of a less favourable
prognosis for neurodynamic5,6 and other interventions, were
prevalent (26/60 and33/60patients, respectively). Therewas indeed
a signiﬁcantly larger improvement for leg pain, back pain, function
and global perceived effect in favour of neurodynamic treatment at
4weeks (aswell as function and global perceived effect immediately
after treatment). We believe that these are valuable outcomes.
Another concern is the choice of Oswestry Disability Index as a
primary outcome over the Patient Speciﬁc Functional Scale, which
was secondary. Maughan and Lewis7 revealed that the Patient-
Speciﬁc Functional Scale was more responsive than the Oswestry
Disability Index and Roland-Morris Disability Index in people with
back pain. In the study by Ferreira et al,1 the Patient-Speciﬁc
Functional Scale results favoured neurodynamic treatment at both
timepoints.
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http://dx.doi.org/10.1016/j.jphys.2016.09.001[1_TD$DIFF] rial [2_TD$DIFF]of [3_TD$DIFF]neurodynamic [4_TD$DIFF]treatment [5_TD$DIFF]was [6_TD$DIFF]reported accurately and appropriatelyWe would like to thank the editor-in-chief of Journal of
Physiotherapy for the opportunity to address Hall and colleagues’
concerns about our randomised trial of neurodynamic treatment
for chronic nerve-related leg pain.1 Hall and colleagues stated that:
the reporting of our results, emphasising the ﬁndings of the
primary outcomes, has led to a binary and oversimpliﬁed
conclusion that neurodynamic treatment ‘does not work[8_TD$DIFF]’ despitethe ﬁndings of some secondary outcomes; the choice of leg pain
and disability as primary outcomes only at 2 weeks, but not at
4 weeks also, was illogical; the selection of the intermediate
follow-up (4 weeks) as the primary outcome would have been
more adequate than the short-term follow-up that we chose; and
we should have considered using the Patient-Speciﬁc Functional
Scale (PSFS) rather than the Oswestry Disability Index (ODI) as one.V. This is an open access article under the CC BY-NC-ND license (http://
Appraisal Correspondence60of the primary outcomes.2 [7_TD$DIFF] Hereafter, we will present several
arguments in response to each of their claims.
Distorted presentation (spin) of the results of randomised trials
is a major concern in healthcare literature because such practices
can negatively impact the decision-making of clinicians, policy
makers and, ultimately, patients. For instance, clinicians who read
randomised trials with abstracts that are written with spin are
more likely to read the full-text article, as well as to rate a
treatment as beneﬁcial despite the absence of statistical signiﬁ-
cance.3 While some authors may feel compelled to write attractive
abstracts even in the absence of statistically signiﬁcant ﬁndings,
this is absolutely inappropriate, because spin in abstracts can
impact the interpretation of the ﬁndings of a trial and eventually
expose patients to potential harms. In addition, selective reporting
of results is quite common in randomised trials of physiotherapy
interventions.4 Taking this into account, we strongly believe that
the results of our interventions must be reported as transparently
as possible. Fortunately, our study was prospectively registered,
the study protocol was previously published5 and the results were
presented in strict accordance with the study’s registry and
protocol.
Hall and colleagues asked for a more thorough interpretation of
the results, not focusing only on primary outcomes; what they
called ‘a more nuanced interpretation[8_TD$DIFF]’. We fail to understand their
proposition, considering that all outcomes were presented in the
article in a descriptivemanner, without any binary judgement calls
about which result was [7_TD$DIFF]‘positive [8_TD$DIFF]’ or [7_TD$DIFF]‘negative [8_TD$DIFF]’. Furthermore, all
outcomes were presented with point estimates and 95% conﬁ-
dence intervals, which allowed the reader to interpret the results
based not only on the observed effect, but also on the uncertainty
around the estimate of the effect. In addition, it was plainly stated
in the conclusion that the proposed treatment did not exert an
effect on the primary outcomes, but [7_TD$DIFF]‘given the beneﬁcial effects on
several secondary outcomes, trials with larger samples and longer
follow-up assessments should be conducted in order to determine
the extent to which the results of these secondary outcomes are
relevant to patients with chronic nerve-related leg pain[8_TD$DIFF]’. Finally,
theWhat this study adds section highlighted that several secondary
outcomes improved signiﬁcantly in the group that received
neurodynamic treatment. We believe that our study provides a
reasonable amount of spin-free information that allows the reader
to adequately interpret our results in light of what they really are,
and not based on what they were supposed to be.
Hall and colleagues stated that they failed to understand the
rationale behind choosing leg pain and disability as primary
outcomes at 2 weeks, but not at 4 weeks. Actually, this is
recommended by the SPIRIT6 [7_TD$DIFF] and CONSORT7 statements, which
advise authors to avoid using several primary outcomes, as well as
outcomes across several time points, as this can introduce
problems with multiplicity, selective reporting and biased
interpretationwhen there are inconsistent results across outcomes
and time points.6 Furthermore, Hall et al criticised the choice of a
short-term follow-up rather than an intermediate-term follow-up
to be the primary outcome. To support their claim, they referencedan editorial article8 that discussed the relevance of studies
designed to assess immediate effects of manual therapy mainly
on surrogate outcomes. This has nothing to do with our selected
primary outcome, as the participants were reassessed after
2 weeks. Besides, we feel that Hall and colleagues are incorrect
in their assumption that choosing short-term follow-ups as the
primary outcome is unconventional. In fact, among all the other
trials published in Journal of Physiotherapy in 2016 that nominated
a single time point for the primary outcome, all nominated the
post-treatment time point and not the follow-up time point.9–11
Furthermore, at the present time there is no evidence to support
the idea that the effects of neurodynamic treatment are likely to
occur in the long-term rather than short-term. As our trial
suggested that this might happen, future studies are required to
examine the extent to which that ﬁnding from our study occurs
consistently.
With regard to the choice of the ODI as a primary outcome
instead of the PSFS, we chose the ODI because it is a widely used
outcomemeasure in low back pain research12 and its use has been
recommended by a panel of experts.13 Likewise, the PSFS has been
gaining attentionmore recently and its use has been encouraged in
clinical trials of low back pain, due to its adequate psychometric
properties such as responsiveness.14 What really matters in this
discussion is that there is consensus that physical functioning is a
core outcome domain that must be evaluated by randomised trials
conducted on populationswith lowback pain;15 and thiswas done.
However, to the best of our knowledge, there is no high-quality
evidence (derived from systematic reviews including high-quality
studies) to support Hall and colleagues’ argument that the PSFS
should have been chosen over the ODI as primary outcome.
Giovanni Ferreira, Fa´bio Stieven, Francisco Araujo,
Matheus Wiebusch, Carolina Rosa, Rodrigo Plentz and
Marcelo Silva
Universidade Federal de Cieˆncias da Sau´de de Porto Alegre, Porto
Alegre, Brazil
References
1. Ferreira G, et al. J Physiother. 2016;62:197–202.
2. Hall T, et al. J Physiother. 2016. http://dx.doi.org/10.1016/j.jphys.2016.09.001.
In press.
3. Boutron I, et al. J Clin Oncol. 2014;32:4120–4126.
4. Pinto RZ, et al. Phys Ther. 2013;93:299–309.
5. Ferreira GE, et al. J Bodyw Mov Ther. 2016. http://dx.doi.org/10.1016/
j.jbmt.2016.02.012. Early online (26 Feb 2016).
6. Chan AW, et al. BMJ. 2013;346:e7586.
7. Moher D, et al. BMJ. 2010;340:c869.
8. Cook C. J Man Manip Ther. 2011;19:3–4.
9. Santana LS, et al. J Physiother. 2016;62:29–34.
10. Harvey LA, et al. J Physiother. 2016;62:88–95.
11. van den Berg M, et al. J Physiother. 2016;62:20–28.
12. Chapman JR, et al. Spine. 2011;36(21 Suppl):S54–S68.
13. Bombardier C. Spine. 2000;25:3100–3103.
14. Costa LO, et al. Spine. 2008;33:2459–2463.
15. Chiarotto A, et al. Eur Spine J. 2015;24:1127–1142.
http://dx.doi.org/10.1016/j.jphys.2016.11.004
